SOLIGENIX, INC. Operating Lease, Liability, Current
SOLIGENIX, INC. (SNGX) had Operating Lease, Liability, Current of $120.52 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Current $120.52K.
- 2026-03-31: Operating Lease, Liability, Current $117.23K.
- 2025-12-31: Operating Lease, Liability, Current $114.02K.
- 2025-09-30: Operating Lease, Liability, Current $111.13K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $120.52K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $117.23K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $114.02K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $111.13K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $108.81K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $79.13K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $111.86K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $132.11K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $128.59K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $125.14K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $121.77K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $118.46K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $115.22K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $112.05K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $108.95K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $106.17K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $103.95K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $75.23K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $106.15K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $136.32K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $165.74K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $194.45K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $112.29K 10-K · filed 2022-03-29 | $222.44K 10-Q · filed 2021-05-18 |
| 2019-12-31 | $113.56K 10-K · filed 2020-03-30 | |
| 2019-09-30 | $145.57K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $176.30K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $206.26K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $235.50K 10-K · filed 2020-03-30 | $235.49K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |